RxDoctor Payments Data

Michael Lu, MD

Diagnostic Radiology · Boston, MANPI 1013242098

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,400 of the $2,533 with a category attached, or 94.8%. Eli Lilly accounts for 94.8% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $2,400, more than ten times the $119 reported in 2019.

$2,533in general payments, 2019–2025

Across 3 payments — averaging $844.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • AstraZeneca$119
  • Amgen$14
$767,832in research payments, 2019–2025

Across 2 payments — averaging $383,916 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Astrazeneca UK Limited$768K

What the payments were for

  • Consulting fees$2,40095%
  • Food & beverage$1335%

General payments by program year

19
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly1$2,400
AstraZeneca1$119
Amgen1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,533 in reported general payments places this provider in the 85th percentile of 1,206 diagnostic radiology providers in Massachusetts.

See all diagnostic radiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$87,210
Medicare patients
1,085
Services billed
2,946

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other diagnostic radiology in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →